Novavax, Inc.

NVAX

$9.98

Name : Novavax, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $1,646,789,888.00

EPSttm : -0.52

Novavax, Inc.

$9.98

2.16%

$0.22

NVAX — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

29.55

Margin Of Safety %

Put/Call OI Ratio

0.55

EPS Next Q Diff

-0.13

EPS Last/This Y

-3.22

EPS This/Next Y

0.38

Price

9.97

Target Price

13.88

Analyst Recom

2.62

Performance Q

22.6

Upside

-161.2%

Beta

2.71

Ticker: NVAX

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-13	NVAX	12.83	0.58	0.07	298355
2026-10-14	NVAX	12.65	0.57	0.16	301856
2026-10-15	NVAX	12.81	0.56	0.11	305225
2026-10-16	NVAX	11.26	0.54	0.42	314913
2026-10-19	NVAX	10.82	0.59	0.37	262230
2026-10-20	NVAX	11.46	0.59	0.14	267362
2026-10-21	NVAX	11.01	0.57	0.25	274607
2026-10-22	NVAX	10.01	0.56	0.32	277477
2026-10-23	NVAX	9.69	0.56	0.44	284999
2026-10-26	NVAX	9.4	0.55	0.17	257588
2026-10-27	NVAX	10.01	0.55	0.04	260866
2026-10-28	NVAX	10.31	0.53	0.02	267361
2026-10-29	NVAX	10.47	0.52	0.22	269511
2026-10-30	NVAX	10.06	0.53	0.15	271685
2026-11-02	NVAX	9.52	0.56	0.50	250990
2026-11-03	NVAX	9.68	0.56	0.72	254838
2026-11-04	NVAX	10.67	0.57	0.61	258133
2026-11-05	NVAX	9.77	0.58	0.14	265042
2026-11-06	NVAX	10.77	0.57	0.36	268179
2026-11-09	NVAX	10.88	0.57	0.19	256602
2026-11-10	NVAX	10.19	0.56	0.21	260712
2026-11-11	NVAX	9.98	0.55	0.08	262342
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-13	NVAX	12.82	11.5	-	-0.58
2026-10-14	NVAX	12.65	11.5	-	-0.58
2026-10-15	NVAX	12.81	11.5	-	-0.59
2026-10-16	NVAX	11.49	11.5	-	-0.59
2026-10-19	NVAX	10.81	11.5	-	-0.52
2026-10-20	NVAX	10.81	11.5	-	-0.52
2026-10-21	NVAX	11.43	11.5	-	-0.52
2026-10-22	NVAX	9.99	11.5	-	-0.52
2026-10-23	NVAX	9.69	11.5	-	-0.52
2026-10-26	NVAX	9.40	11.5	-	-0.52
2026-10-27	NVAX	10.02	11.5	-	-0.52
2026-10-28	NVAX	10.31	11.5	-	-0.52
2026-10-29	NVAX	10.47	11.5	-	-0.52
2026-10-30	NVAX	10.07	11.5	-	-0.59
2026-11-02	NVAX	9.51	11.5	-	-0.59
2026-11-03	NVAX	9.68	11.5	-	-0.50
2026-11-04	NVAX	10.65	11.5	-	-0.50
2026-11-05	NVAX	9.77	11.5	-	-0.50
2026-11-06	NVAX	10.77	11.5	-	-0.50
2026-11-09	NVAX	10.89	-100.0	-	-0.50
2026-11-10	NVAX	10.19	341.8	-	-0.50
2026-11-11	NVAX	9.97	341.8	-	-0.50
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-13	NVAX	0.00	0.32	29.38
2026-10-14	NVAX	0.00	0.32	29.38
2026-10-15	NVAX	0.00	0.32	29.38
2026-10-16	NVAX	0.00	0.32	29.38
2026-10-19	NVAX	0.00	0.30	29.38
2026-10-20	NVAX	0.00	0.30	29.37
2026-10-21	NVAX	0.00	0.30	29.37
2026-10-22	NVAX	0.00	0.30	29.37
2026-10-23	NVAX	0.00	0.30	29.37
2026-10-26	NVAX	0.00	0.31	29.37
2026-10-27	NVAX	0.00	0.31	30.20
2026-10-28	NVAX	0.00	0.31	30.20
2026-10-29	NVAX	0.00	0.31	30.20
2026-10-30	NVAX	0.00	0.31	30.20
2026-11-02	NVAX	0.00	0.26	30.20
2026-11-03	NVAX	0.00	0.26	30.20
2026-11-05	NVAX	0.00	0.26	30.20
2026-11-06	NVAX	0.00	0.26	30.20
2026-11-09	NVAX	0.00	-0.64	30.19
2026-11-10	NVAX	0.00	-0.64	30.19
2026-11-11	NVAX	0.00	-0.64	29.55
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-0.19

Avg. EPS Est. Current Quarter

-0.35

Avg. EPS Est. Next Quarter

-0.32

Insider Transactions

Institutional Transactions

-0.64

Beta

2.71

Average Sales Estimate Current Quarter

123

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

95.8

Max Drawdown 5-Year %

-98.3

Target Price

13.88

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

-0.47

Average EPS Est. Cur. Y

-0.5

EPS Next Y. (Est.)

-0.12

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-18.64

Relative Volume

0.88

Return on Equity vs Sector %

Return on Equity vs Industry %

28.6

EPS 1 7Days Diff

EPS 1 30Days Diff

0.14

EBIT Estimation

◆ NVAX Healthcare

$9.98

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

16/20

Pullback

25/25

Volume

4/15

Valuation

10/20

TP/AR

0/10

Options

7/10

RSI

46.2

Range 1M

22%

Sup Dist

0.4%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

13/25

Growth

7/30

Estimates

0/20

Inst/Vol

4/15

Options

7/10

EPS Yr

-102%

EPS NY

-763%

52W%

51.7%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +39.1% upside

Quality

7/30

Valuation

10/30

Growth

6/25

Stability

7/10

LT Trend

0/5

Upside

+39.1%

Quality

NVAX — P/E HistoricalBiotechnology

Novavax, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 749

Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Serum Life Sciences Limited for the to develop, manufacture, and commercialize the COVID-19 vaccine. The company was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

NVAX

Latest News

—

Caricamento notizie per NVAX…

stock quote shares NVAX – Novavax, Inc. Stock Price stock today

news today NVAX – Novavax, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch NVAX – Novavax, Inc. yahoo finance google finance

stock history NVAX – Novavax, Inc. invest stock market

stock prices NVAX premarket after hours

ticker NVAX fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: NVAX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y